These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 12920173)

  • 1. Concurrent induction and mechanism-based inactivation of CYP3A4 by an L-valinamide derivative.
    Luo G; Lin J; Fiske WD; Dai R; Yang TJ; Kim S; Sinz M; LeCluyse E; Solon E; Brennan JM; Benedek IH; Jolley S; Gilbert D; Wang L; Lee FW; Gan LS
    Drug Metab Dispos; 2003 Sep; 31(9):1170-5. PubMed ID: 12920173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of ritonavir on tissue distribution of a [(14)c]L-valinamide, a potent human immunodeficiency virus-1 protease inhibitor, in rats using quantitative whole-body autoradiography.
    Solon EG; Balani SK; Luo G; Yang TJ; Haines PJ; Wang L; Demond T; Diamond S; Christ DD; Gan LS; Lee FW
    Drug Metab Dispos; 2002 Nov; 30(11):1164-9. PubMed ID: 12386120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro and in vivo effects of the arylamine human immunodeficiency virus protease inhibitor 4R-(4alpha,5alpha,6beta, 7beta)-1-[(3-(1-imidazoylcarbamoyl)phenyl)methyl]-3-[(3-aminophenyl)m ethyl]hexahydro-5,6-dihydroxy-4,7-bis(phenylmethyl)-2H-1, 3-diazepin-2-one (SD894) on rat hepatic cytochrome P450 2B and 3A.
    Grubb MF; Diamond S; Christ DD
    Drug Metab Dispos; 1997 Dec; 25(12):1424-8. PubMed ID: 9394033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A human immunodeficiency virus protease inhibitor is a novel functional inhibitor of human pregnane X receptor.
    Healan-Greenberg C; Waring JF; Kempf DJ; Blomme EA; Tirona RG; Kim RB
    Drug Metab Dispos; 2008 Mar; 36(3):500-7. PubMed ID: 18096673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ritonavir and dexamethasone induce expression of CYP3A and P-glycoprotein in rats.
    Perloff MD; von Moltke LL; Greenblatt DJ
    Xenobiotica; 2004 Feb; 34(2):133-50. PubMed ID: 14985144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of troglitazone on cytochrome P450 enzymes in primary cultures of human and rat hepatocytes.
    Sahi J; Hamilton G; Sinz M; Barros S; Huang SM; Lesko LJ; LeCluyse EL
    Xenobiotica; 2000 Mar; 30(3):273-84. PubMed ID: 10752642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of human hepatocyte cultures to study the induction of cytochrome P-450.
    Kostrubsky VE; Ramachandran V; Venkataramanan R; Dorko K; Esplen JE; Zhang S; Sinclair JF; Wrighton SA; Strom SC
    Drug Metab Dispos; 1999 Aug; 27(8):887-94. PubMed ID: 10421615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased activity of CYP3A enzyme in primary cultures of rat hepatocytes treated with docetaxel: comparative evaluation with paclitaxel.
    Nallani SC; Genter MB; Desai PB
    Cancer Chemother Pharmacol; 2001 Aug; 48(2):115-22. PubMed ID: 11561777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanism-based inactivation of CYP3A by HIV protease inhibitors.
    Ernest CS; Hall SD; Jones DR
    J Pharmacol Exp Ther; 2005 Feb; 312(2):583-91. PubMed ID: 15523003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potent inhibition of the cytochrome P-450 3A-mediated human liver microsomal metabolism of a novel HIV protease inhibitor by ritonavir: A positive drug-drug interaction.
    Kumar GN; Dykstra J; Roberts EM; Jayanti VK; Hickman D; Uchic J; Yao Y; Surber B; Thomas S; Granneman GR
    Drug Metab Dispos; 1999 Aug; 27(8):902-8. PubMed ID: 10421617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatic and intestinal metabolism of indinavir, an HIV protease inhibitor, in rat and human microsomes. Major role of CYP3A.
    Chiba M; Hensleigh M; Lin JH
    Biochem Pharmacol; 1997 Apr; 53(8):1187-95. PubMed ID: 9175724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of cytochrome P450 2C9 expression in primary cultures of human hepatocytes.
    Sahi J; Shord SS; Lindley C; Ferguson S; LeCluyse EL
    J Biochem Mol Toxicol; 2009; 23(1):43-58. PubMed ID: 19202563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolism of endosulfan-alpha by human liver microsomes and its utility as a simultaneous in vitro probe for CYP2B6 and CYP3A4.
    Casabar RC; Wallace AD; Hodgson E; Rose RL
    Drug Metab Dispos; 2006 Oct; 34(10):1779-85. PubMed ID: 16855053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential inhibition of cytochrome P450 3A4, 3A5 and 3A7 by five human immunodeficiency virus (HIV) protease inhibitors in vitro.
    Granfors MT; Wang JS; Kajosaari LI; Laitila J; Neuvonen PJ; Backman JT
    Basic Clin Pharmacol Toxicol; 2006 Jan; 98(1):79-85. PubMed ID: 16433896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of P450 inhibition and induction by artemisinin antimalarials in human liver microsomes and primary human hepatocytes.
    Xing J; Kirby BJ; Whittington D; Wan Y; Goodlett DR
    Drug Metab Dispos; 2012 Sep; 40(9):1757-64. PubMed ID: 22679214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of CYP2B6 in primary human hepatocytes by prototypical inducers.
    Faucette SR; Wang H; Hamilton GA; Jolley SL; Gilbert D; Lindley C; Yan B; Negishi M; LeCluyse EL
    Drug Metab Dispos; 2004 Mar; 32(3):348-58. PubMed ID: 14977870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of cyclophosphamide with and without dexamethasone on cytochrome P450 3A4 and 2B6 in human hepatocytes.
    Lindley C; Hamilton G; McCune JS; Faucette S; Shord SS; Hawke RL; Wang H; Gilbert D; Jolley S; Yan B; LeCluyse EL
    Drug Metab Dispos; 2002 Jul; 30(7):814-22. PubMed ID: 12065440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CYP3A induction by N-hydroxyformamide tumor necrosis factor-alpha converting enzyme/matrix metalloproteinase inhibitors use of a pregname X receptor activation assay and primary hepatocyte culture for assessing induction potential in humans.
    Tippin TK; Hamilton G; Moore L; Beaudet EJ; Jolley S; Brodie TA; Andrews RC; Becherer JD; McDougald DL; Gaul MD; Hoivik DJ; Mellon-Kusibab K; Lehmann J; Kliewer S; Novick S; Laethem R; Zhao Z; LeCluyse EL
    Drug Metab Dispos; 2003 Jul; 31(7):870-7. PubMed ID: 12814963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of the metabolism of midazolam by rifampin in cultured porcine hepatocytes: preliminary evidence for CYP3A isoforms in pigs.
    Hosagrahara VP; Hansen LK; Remmel RP
    Drug Metab Dispos; 1999 Dec; 27(12):1512-8. PubMed ID: 10570035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of a benzyloxy-substituted lactone cyclooxygenase-2 inhibitor as a selective fluorescent probe for CYP3A activity in primary cultured rat and human hepatocytes.
    Nicoll-Griffith DA; Chauret N; Houle R; Day SH; D'Antoni M; Silva JM
    Drug Metab Dispos; 2004 Dec; 32(12):1509-15. PubMed ID: 15550722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.